1. Acknowledgement

   Acknowledgments 30 September 2012 Pages: 775 - 776

2. Effect of Intrinsic and Extrinsic Factors on the Clinical Pharmacokinetics and Pharmacodynamics of Prasugrel

   • David S. Small
   • Nagy A. Farid
   • Daniel E. Salazar

   Review Article 30 September 2012 Pages: 777 - 798

   

3. A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation

   • Hélène M. Faessel
   • R. Scott Obach
   • Aaron H. Burstein

   Review Article 30 September 2012 Pages: 799 - 816

   

4. A Pharmacokinetic and Pharmacodynamic Study of Oral Oxycodone in a Human Experimental Pain Model of Hyperalgesia

   • Anne E. Olesen
   • Richard Upton
   • Asbjørn M. Drewes

   Original Research Article 30 September 2012 Pages: 817 - 827

   

5. Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5mg–10mg) and Determination of Absolute Bioavailability of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects

   • Silke Retlich
   • Vincent Duval
   • Ulrike Graefe-Mody

   Original Research Article 30 September 2012 Pages: 829 - 840